@article{74c8c3e92377444fab2618b864519cd2,
title = "Toward continuous improvement of Scientific Registry of Transplant Recipients performance reporting: Advances following 2012 consensus conference and future consensus building for 2022 consensus conference",
abstract = "The Scientific Registry of Transplant Recipients (SRTR) held a consensus conference in 2012 that examined methods used by SRTR for constructing performance metrics and made recommendations on how to improve program-specific reports. That consensus conference provided 25 recommendations categorized as follows: statistical methods, risk adjustment, and outcomes and data. During the subsequent decade, SRTR has implemented most of these recommendations; these are described in this article along with plans for another consensus conference in 2022. With the present article, SRTR aims to create transparency in the field of transplant metrics and guide discussion in the planning of the next consensus conference in 2022. The new conference will revisit the previous topics and have a broader focus to improve the metrics and information that SRTR provides. Readers can provide feedback on topics to be discussed at the next consensus conference as early as possible, by emailing srtr@srtr.org with the subject line “Task 5 Public Comment.”.",
keywords = "Organ Procurement and Transplantation Network (OPTN), Scientific Registry of Transplant Recipients (SRTR), program-specific reports (PSRs), risk adjustment, statistical methods, transplant outcomes and data",
author = "Israni, {Ajay K.} and Ryutaro Hirose and Segev, {Dorry L.} and Allyson Hart and Schaffhausen, {Cory R.} and Axelrod, {David A.} and Kasiske, {Bertram L.} and Snyder, {Jon J.}",
note = "Funding Information: Dr. Israni has received research funds awarded to Hennepin Healthcare Research Institute from Gilead for investigator‐initiated research related to hepatitis C; is supported by grants and contracts awarded to Hennepin Healthcare from the Health Resources and Services Administration, National Institute of Allergy and Immunology, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Agency of Healthcare Research and Quality; has served on an advisory board for CSL Behring; and receives consulting fees from Medical Review Institute of America. Dr. Axelrod reports consulting for CareDx and Talaris. Drs. Hirose, Segev, Hart, Schaffhausen, Kasiske, and Snyder have no conflicts of interest to report. No involvement of a commercial organization in manuscript preparation or funding. Funding Information: This work was conducted under the auspices of the Hennepin Healthcare Research Institute (HHRI), contractor for the Scientific Registry of Transplant Recipients (SRTR), as a deliverable under contract no. 75R60220C00011 (US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation). The US Government (and others acting on its behalf) retains a paid-up, nonexclusive, irrevocable, worldwide license for all works produced under the SRTR contract, and to reproduce them, prepare derivative works, distribute copies to the public, and perform publicly or display publicly, by or behalf of the Government. The data reported here have been supplied by HHRI as the contractor for SRTR. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy of or interpretation by SRTR or the US Government. The authors thank SRTR colleague Anna Gillette for manuscript editing. A.K.I. is partially supported by AHRQ R01 grant HS 24527. The authors acknowledge participation in the Transplant Peer Review Network and complied with the journal's author guidelines and policies. Funding Information: This work was conducted under the auspices of the Hennepin Healthcare Research Institute (HHRI), contractor for the Scientific Registry of Transplant Recipients (SRTR), as a deliverable under contract no. 75R60220C00011 (US Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation). The US Government (and others acting on its behalf) retains a paid‐up, nonexclusive, irrevocable, worldwide license for all works produced under the SRTR contract, and to reproduce them, prepare derivative works, distribute copies to the public, and perform publicly or display publicly, by or behalf of the Government. The data reported here have been supplied by HHRI as the contractor for SRTR. The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy of or interpretation by SRTR or the US Government. The authors thank SRTR colleague Anna Gillette for manuscript editing. A.K.I. is partially supported by AHRQ R01 grant HS 24527. Publisher Copyright: {\textcopyright} 2022 John Wiley & Sons Ltd. This article has been contributed to by U.S. Government employees and their work is in the public domain in the USA.",
year = "2022",
month = jul,
doi = "10.1111/ctr.14716",
language = "English (US)",
volume = "36",
journal = "Clinical Transplantation",
issn = "0902-0063",
publisher = "Wiley",
number = "7",
}